Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study
Tomasz Pawełczyk, Marta Grancow-Grabka, Natalia Żurner, Agnieszka Pawełczyk
Topics & Concepts
Docosahexaenoic acidEicosapentaenoic acidPolyunsaturated fatty acidInternal medicineSchizophrenia (object-oriented programming)MedicineMetabolic syndromePlaceboRandomized controlled trialTriglycerideEndocrinologyAntipsychoticPositive and Negative Syndrome ScaleGastroenterologyCholesterolPsychiatryFatty acidPsychosisBiologyBiochemistryObesityPathologyAlternative medicineFatty Acid Research and HealthSchizophrenia research and treatmentEicosanoids and Hypertension Pharmacology